Fengchang Qiao, Huasha Zeng, Cuiping Zhang, Yan Wang, Yuguo Wang, Ran Zhou, Lulu Meng, Ping Hu, Zhengfeng Xu
{"title":"A Novel EBP c.452A>G Mutation Identified in a Girl with Conradi-Hünermann-Happle Syndrome Presenting with Hydronephrosis.","authors":"Fengchang Qiao, Huasha Zeng, Cuiping Zhang, Yan Wang, Yuguo Wang, Ran Zhou, Lulu Meng, Ping Hu, Zhengfeng Xu","doi":"10.2147/TACG.S513953","DOIUrl":"10.2147/TACG.S513953","url":null,"abstract":"<p><strong>Background: </strong>Conradi-Hünermann-Happle syndrome (CDPX2, OMIM 302960) is an X-linked dominant inherited disorder caused by variants in the <i>EBP</i> gene, which primarily affects the skin, bones, and eyes.</p><p><strong>Objective: </strong>To describe the clinical manifestations and genetic mutation in a 7-year-old girl presenting with severe scoliosis, hydronephrosis, and other skeletal abnormalities.</p><p><strong>Methods: </strong>The patient's medical history was collected from birth. Exome sequencing was performed to identify candidate genes, and the detected variant was confirmed by Sanger sequencing.</p><p><strong>Results: </strong>Exome sequencing revealed a de novo <i>EBP</i> mutation (c.452A>G, p.Gln151Arg) in the patient.</p><p><strong>Conclusion: </strong>The patient was diagnosed with X-linked chondrodysplasia punctata type 2 (CDPX2). This novel missense mutation expands the mutation spectrum of CDPX2 and underscores the clinical utility of exome sequencing in diagnosing this condition.</p>","PeriodicalId":39131,"journal":{"name":"Application of Clinical Genetics","volume":"18 ","pages":"63-72"},"PeriodicalIF":2.6,"publicationDate":"2025-05-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12085904/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144095335","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Yves Donald Kagambèga, Abdoul Karim Ouattara, Teega-Wendé Clarisse Ouédraogo, Lassina Traoré, Nobila Valentin Yaméogo, Jacques Simpore
{"title":"The Frequency of <i>CYP2C19*2</i> Gene Polymorphisms in Burkina Faso Patients Treated with Clopidogrel.","authors":"Yves Donald Kagambèga, Abdoul Karim Ouattara, Teega-Wendé Clarisse Ouédraogo, Lassina Traoré, Nobila Valentin Yaméogo, Jacques Simpore","doi":"10.2147/TACG.S509095","DOIUrl":"https://doi.org/10.2147/TACG.S509095","url":null,"abstract":"<p><strong>Purpose: </strong>The hepatic cytochrome P450 2C19 (CYP2C19) superfamily plays a crucial role in converting clopidogrel into its active form. Polymorphisms in <i>CYP2C19</i> significantly contribute to the interindividual variability observed, often resulting in persistent thromboembolic complications. This study aimed to assess the frequency of the <i>CYP2C19*2</i> (<i>rs4244285</i>, 681 G>A1) polymorphism among patients with cardiovascular diseases undergoing clopidogrel therapy.</p><p><strong>Patients and methods: </strong>This cross-sectional study recruited a total of seventy-three (73) patients from the Cardiology Department of the Centre Hospitalier Universitaire Yalgado Ouédraogo (CHU-YO) between January and June 2023. DNA was extracted from blood samples for <i>CYP2C19*2</i> genotyping using PCR-RFLP.</p><p><strong>Results: </strong>Genetic analysis revealed frequencies of 65.8% for the wild-type CYP2C19*1/*1, 28.8% for the heterozygous CYP2C19*1/*2, and 2.7% for the homozygous variant CYP2C19*2/*2. The distribution of the genotypic frequencies was consistent with Hardy-Weinberg equilibrium (p> 0.05). The overall frequency of the <i>CYP2C19*2</i> allele in the study population was 16.4%, with 12.5% observed in females and 19.5% in males.</p><p><strong>Conclusion: </strong>This study provides valuable insights into the frequency of the CYP2C19*2 polymorphism among cardiovascular patients in Burkina Faso, contributing to the limited data available on <i>CYP2C19</i> polymorphisms in sub-Saharan Africa. The presence of loss-of-function alleles suggests a potential risk for reduced drug efficacy in a subset of individuals. As one of the pioneering studies in the region, these findings emphasize the importance of further research to understand the clinical implications of <i>CYP2C19</i> polymorphisms.</p>","PeriodicalId":39131,"journal":{"name":"Application of Clinical Genetics","volume":"18 ","pages":"55-61"},"PeriodicalIF":2.6,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12052008/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144003331","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Fco Javier Fernández Martínez, M Mar Gil Mira, Cristina González González, Irene Madrigal Bajo, Raluca Oancea Ionescu, Carmen Orellana Alonso
{"title":"NIPT of Maternal Plasma-Originated cfDNA: Applications and Guide for the Implementation.","authors":"Fco Javier Fernández Martínez, M Mar Gil Mira, Cristina González González, Irene Madrigal Bajo, Raluca Oancea Ionescu, Carmen Orellana Alonso","doi":"10.2147/TACG.S451444","DOIUrl":"https://doi.org/10.2147/TACG.S451444","url":null,"abstract":"<p><p>The implementation of non-invasive prenatal testing (NIPT) in maternal plasma, based on cell-free DNA (cfDNA) analysis, has progressed over the last two decades and is now integrated into the Spanish National Health System. However, there remains significant heterogeneity in its indications, technical methodologies, and reporting standards, reflecting international variability. This guide, developed by experts from the Spanish Association of Prenatal Diagnosis (AEDP) and the Spanish Association of Human Genetics (AEGH), provides recommendations to standardize NIPT application. It addresses key aspects such as technical and analytical requirements, integration with invasive diagnostic methods, pre- and post-test genetic counseling, and legal considerations. Additionally, the guide discusses the detection of common aneuploidies, the limitations in identifying structural chromosomal abnormalities and rare variants, and the impact of biological and clinical factors on test performance. By establishing a minimum framework based on scientific evidence, this document aims to optimize NIPT implementation in a cost-effective manner, ensuring clinical validity and informed decision-making for both healthcare professionals and pregnant women.</p>","PeriodicalId":39131,"journal":{"name":"Application of Clinical Genetics","volume":"18 ","pages":"41-53"},"PeriodicalIF":2.6,"publicationDate":"2025-04-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12046523/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144020328","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Sang Tien Trieu, Minh Duc Pham, Hoang Le, Hien Van Vo, Phong Van Nguyen, Tuan Van Tran, Nhat Ngoc Nguyen, Son The Trinh
{"title":"Survey of Structural Autosomal Abnormalities and Autosomal Variants in Infertile Patients Treated at Some IVF Centers in Vietnam.","authors":"Sang Tien Trieu, Minh Duc Pham, Hoang Le, Hien Van Vo, Phong Van Nguyen, Tuan Van Tran, Nhat Ngoc Nguyen, Son The Trinh","doi":"10.2147/TACG.S510933","DOIUrl":"https://doi.org/10.2147/TACG.S510933","url":null,"abstract":"<p><strong>Background: </strong>Chromosomal abnormalities and variations are significant contributors to reproductive challenges. This study aims to investigate the types and incidence of structural autosomal anomalies and autosomal variations in a large Vietnamese population undergoing infertility treatment. .</p><p><strong>Material and methods: </strong>A retrospective analysis was conducted on 19,191 females and 18,584 males who needed assisted reproductive technology (ART) at the Military Institute of Clinical Embryology and Histology, and Andrology and Fertility Hospital of Hanoi from 2020 to 2023. Karyotyping was conducted using the G-band staining method, and the data were analyzed with STATA 16.0 software.</p><p><strong>Results: </strong>Males have a higher overall occurrence of structural autosomal anomalies, with a total of 359 cases (1.932%) compared to 306 cases (1.594%) in females, particularly inversions and robertsonian translocations. Chromosome 9 inversions were equally observed in both genders, while robertsonian translocations and reciprocal translocations were more frequent in males (0.183% and 0.468%, respectively) than in females (0.146% and 0.406%, respectively). Deletions and duplications were more prevalent in males, occurring at rates of 0.215% and 0.016%, respectively, versus 0.036% and 0.021% in females. Total autosomal variants were 1478 (7.953%) in males and 1864 (9.7%) in females. Chromosome 9 exhibits the highest occurrence of the q+/qh+ variant, followed by the one of chromosome 1 and chromosome 16. Chromosomes 21 and 22 show notable numbers of ps+ and pstk+ variants. .</p><p><strong>Conclusion: </strong>Structural autosomal anomalies and autosomal variations are common in Vietnamese patients undergoing infertility, highlighting the necessity of genetic testing, particularly karyotyping, in the evaluation and management of infertility. .</p>","PeriodicalId":39131,"journal":{"name":"Application of Clinical Genetics","volume":"18 ","pages":"29-40"},"PeriodicalIF":2.6,"publicationDate":"2025-04-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11998953/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143989823","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Beáta Vida, Olga Török, Enikő Felszeghy, Mónika Orosz, Zoárd Tibor Krasznai, Zoltán Tándor, Attila Jakab, Tamás Deli
{"title":"Associations of Karyotype and Age at Diagnosis with Physical Features and Comorbidities in Turner Syndrome: A Single-Site Experience.","authors":"Beáta Vida, Olga Török, Enikő Felszeghy, Mónika Orosz, Zoárd Tibor Krasznai, Zoltán Tándor, Attila Jakab, Tamás Deli","doi":"10.2147/TACG.S492592","DOIUrl":"10.2147/TACG.S492592","url":null,"abstract":"<p><strong>Aim: </strong>Turner syndrome (TS) is one of the most common genetic diseases in females, with typical physical features and comorbidities. Karyotype-phenotype associations and clinical significance of childhood versus adolescent/adulthood diagnosis are conflicting.</p><p><strong>Purpose: </strong>Determining the role of certain TS karyotypes and early (<12 years of age) vs late (≥12 years) diagnosis in TS-specific phenotype and comorbidity penetrance.</p><p><strong>Patients and methods: </strong>Retrospective analysis of baseline characteristics and 45 TS-specific features and comorbidities of 75 TS patients were diagnosed between 2009 and 2019 and followed-up until 2023 in our tertiary care center.</p><p><strong>Results: </strong>Thirteen different karyotypes were detected: 45,X,inv(10), 45,X,inv(9)(15), 45,X, 46,X,i(Xq), 46,X,del(Xp), 46,XX,del(X)q21, 45,X/46,X,del(X), 45,X/46,X,+mar, 45,X/46,X,rX, 45,X/46,XX, 45,X/46,XY, 45,X/47,XXX, 46,X,i(Xq)/47,XX,i(Xq). The classic karyotype with 45X monosomy showed an increased risk for hypertrichosis (28.6% vs 7.5%, OR 4.93, 95% CI [1.23-19.73]), pterygium colli (34% vs 12%, OR 3.65, 95% CI [1.13-11.75]) and short stature (91% vs 75%, OR 3.56 [0.89-14.17]. Mosaic karyotypes had a smaller risk of pterygium colli (OR 0.28 [0.073-1.092]) and short stature (OR 0.29 [0.086-1.026]. 45X/46XX mosaicism was associated with an increased risk of hypertension (33% vs 6%, OR 7.75 [1.39-43.08]), and the presence of the iso (Xq) chromosome increased the risk of celiac disease (28% vs 3%, OR 13.2 [1.52-114.52]). 44/75 (58.6%) of the cohort were diagnosed at <12 years of age. In the <12-year-old diagnosis group, facial dysmorphism and low hairline, (OR 3.30, [1.26-8.65]), low-set ears (OR 2.51 [0.98-6.46]), and breasts abnormalities (OR 4.71 [1.72-12.83]), short stature (OR 4.09 [1.13-14.82]) and GH therapy (OR 4.93 [1.31-16.01]) occurred more frequently. If diagnosed <12 years, patients had a decreased risk of hepatosplenomegaly (OR 0.10 [0.02-0.50]) and hypertension (OR 0.097 [0.01-0.85]).</p><p><strong>Conclusion: </strong>TS patients should be handled as a heterogenous group, as they seem to differ in the penetrance of phenotypical features of the disease and the risk of comorbidities depending on karyotype and age at diagnosis.</p>","PeriodicalId":39131,"journal":{"name":"Application of Clinical Genetics","volume":"18 ","pages":"9-27"},"PeriodicalIF":2.6,"publicationDate":"2025-02-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11834699/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143450530","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Matthew Gordon, Andrew J Gangemi, Eric L Sandwith, Maruti Kumaran, Friedrich Kueppers
{"title":"Vascular Pathology in Alpha 1 Antitrypsin Deficient Chronic Obstructive Pulmonary Disease and Emphysema Patients: Case Reports.","authors":"Matthew Gordon, Andrew J Gangemi, Eric L Sandwith, Maruti Kumaran, Friedrich Kueppers","doi":"10.2147/TACG.S491890","DOIUrl":"10.2147/TACG.S491890","url":null,"abstract":"<p><p>Alpha 1 Antitrypsin Deficiency (AATD) is a genetic condition that results from mutations in the <i>SERPINA1</i> gene, which can lead to deficient or dysfunctional Alpha 1 Antitrypsin (AAT) protein production. AATD is linked to chronic obstructive pulmonary disease (COPD) and emphysema. In addition to pulmonary manifestations, AATD has also been associated with vascular pathology due to excessive protease activity, tissue degradation, and vessel stiffening. Early AATD diagnosis is crucial to prevent progressive lung damage and associated pathologies. Here, we present case reports of two patients with AATD from the Temple University Hospital Outpatient Clinic, who exhibited aneurysms of the aorta and splenic artery. AATD should be considered a genetic risk factor for aneurysms and vascular diseases, necessitating cardiovascular monitoring in affected individuals. This report emphasizes both the need for heightened awareness of AATD as a potential etiology of unexplained vascular aneurysms, as well as the need for screening for vascular pathology in patients with AATD-associated COPD and emphysema to facilitate early intervention and improve patient outcomes.</p>","PeriodicalId":39131,"journal":{"name":"Application of Clinical Genetics","volume":"18 ","pages":"1-7"},"PeriodicalIF":2.6,"publicationDate":"2025-01-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11788590/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143190637","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Bandar Alghanem, Hassan S Alamri, Tlili Barhoumi, Imran Ali Khan, Khawlah Almuhalhil, Essra Aloyouni, Hayat Shaibah, Abdullah Mashhour, Shatha Algheribe, Imadul Islam, Mohamed Boudjelal, Majid Alfadhel
{"title":"First Report from Saudi Arabia of Trimethylaminuria Caused by a Premature Stop Codon Mutation in the <i>FMO3</i> Gene.","authors":"Bandar Alghanem, Hassan S Alamri, Tlili Barhoumi, Imran Ali Khan, Khawlah Almuhalhil, Essra Aloyouni, Hayat Shaibah, Abdullah Mashhour, Shatha Algheribe, Imadul Islam, Mohamed Boudjelal, Majid Alfadhel","doi":"10.2147/TACG.S497959","DOIUrl":"https://doi.org/10.2147/TACG.S497959","url":null,"abstract":"<p><strong>Background: </strong>Trimethylaminuria (TMAU) is a rare recessive genetic disorder with limited global prevalence. To date, there have been no official reports of TMAU cases documented in Saudi Arabia.</p><p><strong>Purpose: </strong>In this study, we developed a liquid chromatography-mass spectrometry (LC-MS) method for the analysis of trimethylamine (TMA) and Trimethylamine N-Oxide (TMAO) in urine and plasma samples for the first reported case of TMAU in Saudi Arabia.</p><p><strong>Patients and methods: </strong>A 41-year-old Saudi man was diagnosed with TMAU in National Guard Hospital. Blood and urine samples were collected to confirm the diagnosis of TMAU. In this study, we have studied LC-MS, cell culture, flow cytometry, adhesion assay and Sanger sequencing analysis. Additionally, in this study, we have selected 5 healthy controls.</p><p><strong>Results: </strong>The results have revealed elevated TMA levels were present in both urine and plasma samples, while TMAO levels were significantly lower compared to control group. Further, we utilized plasma sample from the TMAU patient as novel model to investigate the potential effect of low TMAO on monocyte and endothelial cell function in vitro. DNA sequencing analysis identified a c.622G >T (p.Glu208*) which creates a premature stop codon in FMO3 gene.</p><p><strong>Conclusion: </strong>Our findings revealed differential responses in monocytes and endothelial cells stimulated with plasma from the TMAU patient compared to plasma from non-TMAU patients. These distinct responses may be key modulators of endothelial function and contributes to vascular damage.</p>","PeriodicalId":39131,"journal":{"name":"Application of Clinical Genetics","volume":"17 ","pages":"215-228"},"PeriodicalIF":2.6,"publicationDate":"2024-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11699836/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142932985","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Tadeusz Kałużewski, Iwona Pinkier, Urszula Wysocka, Jordan Sałamunia, Łukasz Kępczyński, Małgorzata Piotrowicz, Bogdan Kałużewski, Agnieszka Gach
{"title":"Expanding the Molecular Landscape of Androgen Insensitivity Syndrome Through Next-Generation Sequencing.","authors":"Tadeusz Kałużewski, Iwona Pinkier, Urszula Wysocka, Jordan Sałamunia, Łukasz Kępczyński, Małgorzata Piotrowicz, Bogdan Kałużewski, Agnieszka Gach","doi":"10.2147/TACG.S498338","DOIUrl":"10.2147/TACG.S498338","url":null,"abstract":"<p><p>Androgen insensitivity syndrome (AIS) is an X-linked genetic disorder caused by mutations in the androgen receptor gene (<i>AR</i>), leading to impaired androgen signaling and resulting in varying degrees of undermasculinization in individuals with a 46,XY karyotype. This study aimed to expand the molecular landscape of AIS by identifying and characterizing pathogenic variants in the <i>AR</i> gene via next-generation sequencing (NGS). Molecular diagnostics revealed eight distinct variants within the <i>AR</i> gene, two of which had not been previously described. These include the following novel variants: c.3G>A, and c.1344_1345insTA. This study broadens the spectrum of known <i>AR</i> gene mutations associated with AIS and highlights the critical role of molecular diagnostics in the accurate classification of variants. These findings will aid in enhancing the clinical management and genetic counseling of individuals affected by AIS.</p>","PeriodicalId":39131,"journal":{"name":"Application of Clinical Genetics","volume":"17 ","pages":"205-214"},"PeriodicalIF":2.6,"publicationDate":"2024-12-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11669279/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142898884","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Bilateral Wilms Tumor - Case Report of a Patient with Family History.","authors":"Oliwia Rdzanek, Patrycja Najda, Karolina Parysek-Wójcik, Anna Pytlik, Monika Lejman, Joanna Zawitkowska","doi":"10.2147/TACG.S495498","DOIUrl":"10.2147/TACG.S495498","url":null,"abstract":"<p><p>Wilms' tumor (WT) is the most common renal neoplasm in children. Despite its rapid growth, it is often asymptomatic. It most commonly occurs between the ages of 3 and 5, more frequently in girls. Numerous studies report an association between the occurrence of Wilms' tumor and genetic background. Treatment of bilateral Wilms' tumor (BWT) presents several challenges. Recent studies raise the issue of the influence of genetics on the development of BWT. We believe that our case report is innovative as it provides information on a rare clinical presentation and comprehensively addresses the potential impact of genetic studies on favorable treatment outcomes, which are discussed only in limited detail in the literature. The case description concerns a 2-year-old and a 5-month-old patient who presented with his mother due to a change in abdominal contour. In the medical history, the boy's mother had been treated for WT. Imaging of the abdominal cavity revealed the presence of pathological tissue changes in both kidneys. Based on this, stage V Wilms' tumor was diagnosed. The boy underwent a right-sided tumor nephrectomy followed by a left-sided heminephrectomy. He also received pre- and post-operative chemotherapy. Genetic testing revealed a deletion fragment of exon 8 and exons 9-10 on one allele of the <i>WT1</i> gene. Despite optimistic data regarding overall survival in children with WT, a significant clinical issue remains with patients experiencing disease recurrence and bilateral BWT. Radical treatment is often required for such patients, which carries long-term consequences. Identifying patients at risk for familial WT or BWT allows for relatively early intervention and effective prevention. Furthermore, certain gene variants associated with WT can be considered prognostic biomarkers.</p>","PeriodicalId":39131,"journal":{"name":"Application of Clinical Genetics","volume":"17 ","pages":"199-203"},"PeriodicalIF":2.6,"publicationDate":"2024-12-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11660652/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142878283","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Agata Rocka, Maria Suchcicka, Aleksandra M Jankowska, Magdalena M Woźniak, Monika Lejman
{"title":"Pathway of LCK Tyrosine Kinase and mTOR Signaling in Children with T-Cell Acute Lymphoblastic Leukemia.","authors":"Agata Rocka, Maria Suchcicka, Aleksandra M Jankowska, Magdalena M Woźniak, Monika Lejman","doi":"10.2147/TACG.S494389","DOIUrl":"10.2147/TACG.S494389","url":null,"abstract":"<p><p>The aim of this study is to analyze available research on targeting signaling pathways for the development of new drugs in patients with T-cell acute lymphoblastic leukemia (T-ALL). This analysis focuses specifically on the role of LCK tyrosine kinase and mTOR signaling pathways in pediatric patients. Outcome: Current literature suggests that these pathways play a significant role in the regulation of T-cell cycles, making them potential therapeutic targets. However, despite promising findings, there remains a need for further research, particularly in pediatric populations, to fully understand the therapeutic implications and to optimize drug development. The conclusion drawn from this analysis highlights the significant influence of LCK and mTOR on T-cell cycle regulation, underscoring the importance of continued investigation in this area.</p>","PeriodicalId":39131,"journal":{"name":"Application of Clinical Genetics","volume":"17 ","pages":"187-198"},"PeriodicalIF":2.6,"publicationDate":"2024-11-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11585986/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142711172","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}